Insider Transactions in Q4 2025 at Pasithea Therapeutics Corp. (KTTA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2025
|
Lawrence Steinman Director |
BUY
Open market or private purchase
|
Direct |
133,333
+40.04%
|
$0
$0.75 P/Share
|
|
Nov 28
2025
|
Daniel H Schneiderman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,667
+50.0%
|
$0
$0.75 P/Share
|
|
Nov 28
2025
|
Tiago Marques Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
33,333
+31.25%
|
$0
$0.75 P/Share
|
|
Nov 28
2025
|
Emer Leahy Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+50.0%
|
$0
$0.75 P/Share
|
|
Nov 28
2025
|
Simon Dumesnil Director |
BUY
Open market or private purchase
|
Direct |
33,333
+48.19%
|
$0
$0.75 P/Share
|